feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Jalen Johnson leads Hawks victory

trending

IRS stimulus direct deposit rumors

trending

Nvidia: 'one team' culture

trending

Retirement income policies review

trending

Virus linked to lupus cases

trending

Bitcoin price drops below $100,000

trending

FIFA U-17 World Cup thrills

trending

Walmart CEO Doug McMillon retires

trending

Alibaba AI app relaunch planned

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / India Faces Alarming Surge in Chronic Kidney Disease, a Leading Cause of Death

India Faces Alarming Surge in Chronic Kidney Disease, a Leading Cause of Death

14 Nov

•

Summary

  • Chronic kidney disease now 9th leading cause of death globally
  • India has world's 2nd highest number of CKD patients at 138 million
  • Experts call for urgent action on screening and public awareness

According to a recent Lancet study led by the University of Glasgow, chronic kidney disease (CKD) has emerged as the 9th leading cause of death globally, responsible for 1.48 million lives annually. This growing crisis is particularly acute in India, which as of 2025 had the world's second-highest number of CKD patients, with an estimated 138 million adults affected.

Health experts note that CKD has become a major public health concern in India, mirroring worrying global trends. The Global Burden of Disease 2023 study reveals that CKD cases have surged worldwide over the past three decades, with the number of people living with the condition rising from 378 million in 1990 to 788 million in 2023. South Asia, including India, has one of the highest adult CKD prevalence rates at 15.8%.

Compounding the issue, CKD's early stages often present no symptoms, meaning many Indians may remain unaware of their condition until it progresses. Researchers are now urging urgent action to improve prevention, detection, and public awareness of this "silent" disease. Implementing routine CKD screening programs and boosting awareness can help catch the condition sooner, when treatments are most effective at slowing its advancement.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
According to the article, India had the world's second-highest number of chronic kidney disease (CKD) patients in 2023, with an estimated 138 million adults affected by the condition.
The article states that CKD has become a major public health concern for India, mirroring global trends that have seen the disease climb to the 9th leading cause of death worldwide, responsible for 1.48 million lives annually.
The article mentions that experts are urging urgent steps to counter this growing crisis through better prevention, detection, and public awareness. This includes implementing routine CKD screening programs and increasing public awareness about the disease.

Read more news on

Indiaside-arrowHealthside-arrow

You may also like

Scotland Trials Valium Prescriptions to Curb Addiction Deaths

13 Nov • 12 reads

article image

Novartis Unveils GanLum, a Next-Gen Anti-Malaria Drug Offering Hope Against Resistance

13 Nov • 13 reads

Sheffield Researchers Discover Potential Breakthrough Treatment for Motor Neurone Disease

11 Nov • 16 reads

article image

Endocrinologist Dazzles Crowd with Surprise Moonwalk Performance

2 Nov • 40 reads

article image

Fossil Fuels Claim 1.72 Million Lives in India: Devastating Health Toll Revealed

29 Oct • 20 reads

article image